Literature DB >> 35378260

Rethinking the central role of mast cells in virally mediated asthma exacerbations.

Larry Borish1.   

Abstract

Entities:  

Year:  2022        PMID： 35378260      PMCID： PMC9526754          DOI： 10.1016/j.anai.2022.03.029

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN： 1081-1206            Impact factor:   6.248


× No keyword cloud information.
  10 in total

1.  Human TH1 and TH2 cells targeting rhinovirus and allergen coordinately promote allergic asthma.

Authors:  Lyndsey M Muehling; Peter W Heymann; Paul W Wright; Jacob D Eccles; Rachana Agrawal; Holliday T Carper; Deborah D Murphy; Lisa J Workman; Carolyn R Word; Sarah J Ratcliffe; Brian J Capaldo; Thomas A E Platts-Mills; Ronald B Turner; William W Kwok; Judith A Woodfolk
Journal:  J Allergy Clin Immunol       Date:  2020-04-19       Impact factor: 10.793

2.  Understanding the asthmatic response to an experimental rhinovirus infection: Exploring the effects of blocking IgE.

Authors:  Peter W Heymann; Thomas A E Platts-Mills; Judith A Woodfolk; Larry Borish; Deborah D Murphy; Holliday T Carper; Mark R Conaway; John W Steinke; Lyndsey Muehling; W Gerald Teague; Joshua L Kennedy; Anne-Marie Irani; Matthew D McGraw; Stephen V Early; Lisa M Wheatley; Amy P Adams; Ronald B Turner
Journal:  J Allergy Clin Immunol       Date:  2020-02-01       Impact factor: 10.793

3.  Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care. IgE and eosinophil analyses.

Authors:  G P Rakes; E Arruda; J M Ingram; G E Hoover; J C Zambrano; F G Hayden; T A Platts-Mills; P W Heymann
Journal:  Am J Respir Crit Care Med       Date:  1999-03       Impact factor: 21.405

4.  Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children.

Authors:  William W Busse; Wayne J Morgan; Peter J Gergen; Herman E Mitchell; James E Gern; Andrew H Liu; Rebecca S Gruchalla; Meyer Kattan; Stephen J Teach; Jacqueline A Pongracic; James F Chmiel; Suzanne F Steinbach; Agustin Calatroni; Alkis Togias; Katherine M Thompson; Stanley J Szefler; Christine A Sorkness
Journal:  N Engl J Med       Date:  2011-03-17       Impact factor: 91.245

Review 5.  Novel cytokines and cytokine-producing T cells in allergic disorders.

Authors:  Julia A Wisniewski; Larry Borish
Journal:  Allergy Asthma Proc       Date:  2011 Mar-Apr       Impact factor: 2.587

6.  Interleukin-13-induced mucous metaplasia increases susceptibility of human airway epithelium to rhinovirus infection.

Authors:  Marrah E Lachowicz-Scroggins; Homer A Boushey; Walter E Finkbeiner; Jonathan H Widdicombe
Journal:  Am J Respir Cell Mol Biol       Date:  2010-01-15       Impact factor: 6.914

7.  Experimental rhinovirus challenges in adults with mild asthma: response to infection in relation to IgE.

Authors:  Juan C Zambrano; Holliday T Carper; Gary P Rakes; James Patrie; Deborah D Murphy; Thomas A E Platts-Mills; Frederick G Hayden; Jack M Gwaltney; Tina K Hatley; Angela M Owens; Peter W Heymann
Journal:  J Allergy Clin Immunol       Date:  2003-05       Impact factor: 10.793

Review 8.  Airway innate lymphoid cells in the induction and regulation of allergy.

Authors:  Taylor A Doherty; David H Broide
Journal:  Allergol Int       Date:  2018-11-23       Impact factor: 5.836

9.  Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing.

Authors:  Peter W Heymann; Holliday T Carper; Deborah D Murphy; Thomas A E Platts-Mills; James Patrie; Anne P McLaughlin; Elizabeth A Erwin; Marcus S Shaker; Martha Hellems; Jehanna Peerzada; Frederick G Hayden; Tina K Hatley; Rachel Chamberlain
Journal:  J Allergy Clin Immunol       Date:  2004-08       Impact factor: 10.793

10.  KIT Inhibition by Imatinib in Patients with Severe Refractory Asthma.

Authors:  Katherine N Cahill; Howard R Katz; Jing Cui; Juying Lai; Shamsah Kazani; Allison Crosby-Thompson; Denise Garofalo; Mario Castro; Nizar Jarjour; Emily DiMango; Serpil Erzurum; Jennifer L Trevor; Kartik Shenoy; Vernon M Chinchilli; Michael E Wechsler; Tanya M Laidlaw; Joshua A Boyce; Elliot Israel
Journal:  N Engl J Med       Date:  2017-05-18       Impact factor: 91.245
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.